FDA Approval Summary: Olaparib Monotherapy in Patients with Deleterious Germline <i>BRCA</i>-Mutated Advanced Ovarian Cancer Treated with Three or More Lines of ChemotherapyGeoffrey Kim, Richard Pazdur, Shenghui Tang et al.|Clinical Cancer Research|2015Cited by 526
European Respiratory Society clinical practice guideline on symptom management for adults with serious respiratory illnessAnne E. Holland, Magnus Ekström, Anna Spathis et al.|European Respiratory Journal|2024Cited by 73